Australia, Feb. 18 -- Amgen Inc., owns the trademark (2503683) for 'BEMTUVIK' till Dec. 3, 2034.
Status: registered:
Registered/protected
Classes: 5 [Pharmaceutical preparations and substances for the treatment of cancer and cardiovascular diseases and disorders; pharmaceutical preparations and substances for the treatment of oncological diseases and disorders; pharmaceutical preparations for the treatment of gastric and gastro-esophageal diseases, conditions or maladies; other pharmaceutical preparations.] and 5 [Pharmaceutical preparations and substances for the treatment of cancer and cardiovascular diseases and disorders;pharmaceutical preparations and substances for the treatment of oncological diseases and disorders;pharmaceutical preparations for the treatment of gastric and gastro-esophageal diseases, conditions or maladies;other pharmaceutical preparations]
Type of Mark: Word
Date of Acceptance: Dec. 9, 2024
Registration Advertised: Feb. 17
For further details contact Spruson & Ferguson.
The original document can be viewed at: https://search.ipaustralia.gov.au/trademarks/search/view/2503683.
Disclaimer: Curated by HT Syndication.
